Enzyme flexibility, solvent and ‘weak’ interactions characterize thrombin–ligand interactions: implications for drug design
Open Access
- 15 November 1996
- Vol. 4 (11) , 1353-1362
- https://doi.org/10.1016/s0969-2126(96)00142-6
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Conversion of thrombin into an anticoagulant by protein engineeringNature, 1995
- X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B.Proceedings of the National Academy of Sciences, 1995
- Thrombin active site inhibitorsBioorganic & Medicinal Chemistry, 1995
- The clot thickens: clues provided by thrombin structureTrends in Biochemical Sciences, 1995
- The X-Ray Crystal Structure of Thrombin in Complex with Nα-2-Naphthylsulfonyl-L-3-Amidino-Phenylalanyl-4-Methylpiperidide: The Beneficial Effect of Filling Out an Empty CavityJournal of Enzyme Inhibition, 1995
- Coagulation factors and their inhibitorsCurrent Opinion in Structural Biology, 1994
- The isomorphous structures of prethrombin2, hirugen–, and PPACK–thrombin: Changes accompanying activation and exosite binding to thrombinProtein Science, 1994
- Rational design of hirulog-type inhibitors of thrombinJournal of Computer-Aided Molecular Design, 1994
- Structure of Human Des(1-45) Factor Xa at 2·2 Å ResolutionJournal of Molecular Biology, 1993
- The refined 1.9‐Å X‐ray crystal structure of d‐Phe‐Pro‐Arg chloromethylketone‐inhibited human α‐thrombin: Structure analysis, overall structure, electrostatic properties, detailed active‐site geometry, and structure‐function relationshipsProtein Science, 1992